The current understanding of Stevens–Johnson syndrome and toxic epidermal necrolysis

The ophthalmologic Management of Acute Stevens-Johnson Syndrome

(2012) Darren G. Gregory   Ocular Surface

Drug hypersensitivity: Pharmacogenetics and clinical syndromes

(2011) Elizabeth J. Phillips et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Immune pathomechanism of drug hypersensitivity reactions

(2011) Werner J. Pichler et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis

(2010) L. Valeyrie-Allanore et al.   BRITISH JOURNAL OF DERMATOLOGY

ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis

(2010) B Sassolas et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis

(2010) Esther Morel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Successful Treatment of Stevens-Johnson Syndrome with Steroid Pulse Therapy at Disease Onset

(2009) Yayoi Araki et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes

(2009) Manuel Florian Struck et al.   INTENSIVE CARE MEDICINE

Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis

(2008) Wen-Hung Chung et al.   NATURE MEDICINE

A European study of HLA-B in Stevens???Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

(2008) Christine Lonjou et al.   Pharmacogenetics and Genomics

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study

(2007) Maja Mockenhaupt et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel

(2007) Sima Halevy et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study

(2007) Jürgen Schneck et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY